(MedPage Today) — A quadrivalent modified mRNA influenza vaccine was more efficacious than a standard quadrivalent inactivated flu vaccine, a randomized phase III trial showed.
During the 2022-2023 flu season among people ages 18 to 64, the relative…
Source link : https://www.medpagetoday.com/infectiousdisease/uritheflu/118607
Author :
Publish date : 2025-11-19 22:00:00
Copyright for syndicated content belongs to the linked Source.
